Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study

RA Rudd, 2016, Increases in drug and opioid overdose deaths—united states, 2000–2014, MMWR Morb Mortal Wkly Rep, 64, 1378, 10.15585/mmwr.mm6450a3

CS Florence, 2016, The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013, Med Care, 54, 901, 10.1097/MLR.0000000000000625

NY Kirson, 2015, The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals, Pain Med, 16, 1325, 10.1111/pme.12768

H Jalal, 2018, Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016, Sci, 361, eaau1184, 10.1126/science.aau1184

RB Bolash, 2015, Trends in opioid analgesic abuse and mortality in the United States, N Engl J Med, 372, 1573

GP Guy, 2017, Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015, MMWR Morb Mortal Wkly Rep, 66, 697, 10.15585/mmwr.mm6626a4

RA Rudd, 2016, Increases in Drug and Opioid-Involved Overdose Deaths—United States, 2010–2015, MMWR Morb Mortal Wkly Rep, 65, 1445, 10.15585/mmwr.mm655051e1

JK O'Donnell, 2017, Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region—United States, 2006–2015, MMWR Morb Mortal Wkly Rep, 66, 897, 10.15585/mmwr.mm6634a2

WM Compton, 2016, Relationship between Nonmedical Prescription-Opioid Use and Heroin Use, N Engl J Med, 374, 154, 10.1056/NEJMra1508490

B Han, 2017, Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health, Ann Intern Med, 167, 293, 10.7326/M17-0865

D Dowell, 2016, CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016, MMWR Recomm Rep, 65, 1, 10.15585/mmwr.rr6501e1

D Dowell, 2016, Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates, Health Aff (Millwood), 35, 1876, 10.1377/hlthaff.2016.0448

R Rubin, 2018, CMS to Improve Drug Programs and Opioid Overuse Oversight, JAMA, 319, 1189, 10.1001/jama.2018.2785

M Gabay, 2015, Prescription Drug Monitoring Programs, Hosp Pharm, 50, 277, 10.1310/hpj5004-277

YJ Wei, 2019, Performance of the Centers for Medicare & Medicaid Services' Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose, JAMA, 321, 609, 10.1001/jama.2018.20404

RC Dart, 2015, Trends in opioid analgesic abuse and mortality in the United States, N Engl J Med, 372, 241, 10.1056/NEJMsa1406143

DS Nagin, 2010, Group-based trajectory modeling in clinical research, Annu Rev Clin Psychol, 6, 109, 10.1146/annurev.clinpsy.121208.131413

CA Green, 2017, Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records, Pharmacoepidemiol Drug Saf, 26, 509, 10.1002/pds.4157

The Centers for Medicare and Medicaid Services, 2018, Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors

MJ Edlund, 2007, Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain, Pain, 129, 355, 10.1016/j.pain.2007.02.014

MJ Edlund, 2010, Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study, Drug and Alcohol Depen, 112, 90, 10.1016/j.drugalcdep.2010.05.017

BL Wilsey, 2008, Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department, Pain Med, 9, 1107, 10.1111/j.1526-4637.2007.00401.x

BN Cochran, 2014, Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals, Drug and Alcohol Depen, 138, 202, 10.1016/j.drugalcdep.2014.02.701

M Von Korff, 2017, Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives, Int J Drug Policy, 46, 90, 10.1016/j.drugpo.2017.05.053

KC Heslin, 2017, Trends in Opioid-related Inpatient Stays Shifted After the US Transitioned to ICD-10-CM Diagnosis Coding in 2015, Med Care, 55, 918, 10.1097/MLR.0000000000000805

G Zou, 2004, A modified poisson regression approach to prospective studies with binary data, Am J Epidemiol, 159, 702, 10.1093/aje/kwh090

H Andruff, 2009, Latent Class Growth Modelling: A Tutorial, Tutor Quant Methods Psychol, 5, 11, 10.20982/tqmp.05.1.p011

ASB Bohnert, 2018, Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline, Ann Intern Med, 169, 367, 10.7326/M18-1243

L Scholl, 2018, Drug and Opioid-Involved Overdose Deaths—United States, 2013–2017, MMWR Morb Mortal Wkly Rep, 67, 1419, 10.15585/mmwr.mm675152e1

TJ Cicero, 2014, The changing face of heroin use in the United States: a retrospective analysis of the past 50 years, JAMA Psychiatry, 71, 821, 10.1001/jamapsychiatry.2014.366

SP Stumbo, 2017, Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement, J Subst Abuse Treat, 73, 47, 10.1016/j.jsat.2016.11.003

CJ Mistry, 2014, Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence, Curr Psychiatry Rev, 10, 156, 10.2174/1573400510666140320000928

AD Adewumi, 2018, Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose, CNS Drugs, 32, 101, 10.1007/s40263-018-0499-3

KE Evoy, 2017, Abuse and Misuse of Pregabalin and Gabapentin, Drugs, 77, 403, 10.1007/s40265-017-0700-x

S Slavova, 2018, Prevalence of gabapentin in drug overdose postmortem toxicology testing results, Drug and Alcohol Depen, 186, 80, 10.1016/j.drugalcdep.2018.01.018

RV Smith, 2016, Gabapentin misuse, abuse and diversion: a systematic review, Addiction, 111, 1160, 10.1111/add.13324

US Food and Drug Administration, 2017, FDA requests removal of Opana ER for risks related to abuse

CM Jones, 2015, Vital Signs: Demographic and Substance Use Trends Among Heroin Users—United States, 2002–2013, MMWR Morb Mortal Wkly Rep, 64, 719

J Fudin, 2018, Safety concerns with the Centers for Disease Control opioid calculator, J Pain Res, 11, 1, 10.2147/JPR.S155444